Article

Latest Medical and Laser Therapy

Chicago-Reducing the IOP level is the first goal when treating patientswith open-angle glaucoma. The latest research indicates that keeping IOPin check benefits patients by protecting the optic nerve from damage andpreserving the visual field. However, individualized patient treatment todetermine the IOP range that works best to control IOP is the challenge.Stephen A. Obstbaum, MD, discussed setting that range for individual patientsand the most beneficial therapy with a workable risk/benefit ratio-bothof which should meet the ultimate challenge of preserving vision and qualityof life.

Related Videos
(Image credit: Ophthalmology Times) NeuroOp Guru: The role of muscle biopsy in heteroplasmy detection
(Image credit: Ophthalmology Times) AGS 2025: Achieving success as an academic ophthalmologist with Thomas V. Johnson III, MD, PhD
(Image credit: Ophthalmology Times) AGS 2025: Constance Okeke, MD, highlights 1-year Streamline canaloplasty outcomes
(Image credit: Ophthalmology Times) AGS 2025: Telemedicine and genetics for resource-efficient care with Louis R. Pasquale, MD
© 2025 MJH Life Sciences

All rights reserved.